Targeting ZBP-89 for the treatment of hepatocellular carcinoma

Expert Opinion on Therapeutic Targets
Nuozhou WangGeorge Chen

Abstract

Zinc-binding protein-89 (ZBP-89) is a Krüppel-type zinc-finger transcription factor that regulates target gene expression profiles via directly binding to GC-rich gene promoters, recruiting chromatin modifiers or by interacting with other proteins. The importance of ZBP-89 in the regulation of cell cycle arrest and apoptosis has led to increased interest and investigations for its role in cancer development. Areas covered: We describe ZBP-89 as a candidate therapeutic target for hepatocellular carcinoma (HCC) from several perspectives. ZBP-89 can upregulate apoptosis in HCC in a p53-dependent or - independent manner. In addition, the negative regulation of ZBP-89 on liver cancer stemness sheds light on its possible effect on sensitizing HCC to chemotherapies and the reduction of HCC relapse. The prognostic significance of ZBP-89 in HCC patients further suggests its clinical importance as a potential tumor suppressor. Expert opinion: Given the roles of ZBP-89 in HCC, we believe, ZBP-89 is a promising therapeutic target for enhancing apoptosis and diminishing the liver cancer stemness. At the same time, we also face a series of challenges, especially in the clinical implication of ZBP-89. Resolving the current controversies will ...Continue Reading

References

Apr 7, 1997·Biochemical and Biophysical Research Communications·T TaniuchiJ L Merchant
Mar 6, 1999·Biochemical and Biophysical Research Communications·T HasegawaK Isobe
Jun 21, 2001·Molecular and Cellular Biology·L Bai, J L Merchant
May 29, 2003·Nucleic Acids Research·Xueping ZhangZendra E Zehner
Jul 4, 2003·The Journal of Nutrition·Juanita L MerchantMorihiro Okada
Dec 5, 2003·Nucleic Acids Research·Longchuan Bai, Juanita L Merchant
Jan 28, 2004·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Aurora O'Brate, Paraskevi Giannakakou
Feb 14, 2004·Cell Death and Differentiation·L BaiJ L Merchant
Dec 23, 2004·Journal of Virology·Elizabeth A Holley-GuthrieShannon C Kenney
Jun 15, 2007·Biochemical and Biophysical Research Communications·Longchuan Bai, Juanita L Merchant
Oct 18, 2007·The Journal of Biological Chemistry·Sergey ChupretaJorge A Iñiguez-Lluhí
Aug 6, 2010·Pathology and Laboratory Medicine International : PLMI·Ruth C Borghaei, Mariah Chambers
Aug 21, 2013·Biochimica Et Biophysica Acta·Cai Guo YePaul B S Lai
Jan 28, 2015·Journal of Translational Medicine·Cai Guo YePaul B S Lai
Jul 15, 2016·Journal of Biomedical Science·Jayu Jen, Yi-Ching Wang
Aug 4, 2016·Oncotarget·Anna NiltonPer Lindahl
Dec 8, 2017·Oncotarget·Ramon Ocadiz-RuizJuanita L Merchant

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis